RM
RP Management Portfolio holdings
AUM
$139M
This Quarter Return
-15.99%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$245M
AUM Growth
+$245M
(-18%)
Cap. Flow
-$1.16M
Cap. Flow
% of AUM
-0.47%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$1.16M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $144M | 54.16% | 2,111,111 | – | – |
|
|
EPZM
2
DELISTED
Epizyme, Inc
EPZM
| $79.8M | 29.97% | 9,166,667 | – | – |
|
3
Cytokinetics
CYTK
$4.23B
| $20.4M | 7.65% | 875,656 | – | – |
|
|
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $34K | 0.01% | 3,700 -125,817 | -97% | -$1.16M |
|